<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathogens</journal-id><journal-id journal-id-type="iso-abbrev">Pathogens</journal-id><journal-id journal-id-type="publisher-id">pathogens</journal-id><journal-title-group><journal-title>Pathogens</journal-title></journal-title-group><issn pub-type="epub">2076-0817</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6963929</article-id><article-id pub-id-type="doi">10.3390/pathogens8040181</article-id><article-id pub-id-type="publisher-id">pathogens-08-00181</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Rational Explanation of Limited FMD Vaccine Uptake in Endemic Regions</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0763-5397</contrib-id><name><surname>Railey</surname><given-names>Ashley F.</given-names></name><xref ref-type="aff" rid="af1-pathogens-08-00181">1</xref><xref ref-type="aff" rid="af2-pathogens-08-00181">2</xref><xref rid="c1-pathogens-08-00181" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Marsh</surname><given-names>Thomas L.</given-names></name><xref ref-type="aff" rid="af2-pathogens-08-00181">2</xref><xref ref-type="aff" rid="af3-pathogens-08-00181">3</xref></contrib></contrib-group><aff id="af1-pathogens-08-00181"><label>1</label>Institute for Research and Education to Advance Community Health, College of Medicine, Washington State University, Pullman, WA 99163, USA</aff><aff id="af2-pathogens-08-00181"><label>2</label>Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA 99163, USA</aff><aff id="af3-pathogens-08-00181"><label>3</label>School of Economic Sciences, Washington State University, Pullman, WA 99163, USA</aff><author-notes><corresp id="c1-pathogens-08-00181"><label>*</label>Correspondence: <email>ashley.railey@wsu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2019</year></pub-date><volume>8</volume><issue>4</issue><elocation-id>181</elocation-id><history><date date-type="received"><day>17</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>08</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Vaccination for foot-and-mouth (FMD) disease remains low in parts of Africa despite the existence of vaccines. In East Africa, the presence of multiple virus serotypes and sub-types makes matching a vaccine with the circulating virus type in the field, or providing a high potency vaccine, a challenge. In this paper we use game theory to show that the resulting vaccine uncertainty associated with these vaccination conditions in an endemic setting help explain the low vaccine uptake. We evaluate vaccination for FMD in the context of East Africa due to FMD being endemic in the region, the diversity of FMD virus types, and barriers to implementing other disease control measures, such as controlled movements. We incorporate these conditions into a vaccination game setting and compare the payoffs to those of a traditional vaccination game for seasonal influenza and commercial livestock vaccination in a developed country context. In showing that vaccination provides households with a lower payoff than not vaccinating, our simple game theoretical explanation supports existing evidence calling for improved vaccine quality and efforts to enhance surveillance to provide early information on disease status.</p></abstract><kwd-group><kwd>Foot-and-mouth disease</kwd><kwd>game theory</kwd><kwd>vaccination</kwd><kwd>vaccines</kwd><kwd>uncertainty</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pathogens-08-00181"><title>1. Introduction</title><p>Individuals may decide not to employ disease control measures despite availability and public health recommendations due to individual beliefs and perspectives [<xref rid="B1-pathogens-08-00181" ref-type="bibr">1</xref>]. Vaccination in human and animal health presents one such case. The decision to vaccinate affects the vaccinated human/animal and contributes to population immunity by reducing the number of susceptible individuals within the community. In contrast, non-vaccinators can ignite and prolong an outbreak depending on who vaccinates, how many remain unvaccinated, and the transmission dynamics of the disease [<xref rid="B2-pathogens-08-00181" ref-type="bibr">2</xref>]. The decision not to vaccinate may be driven by self-interest, information barriers, and the intention to free ride on the protective immunity of others. For human vaccination, concerns for adverse personal side effects can affect adoption [<xref rid="B3-pathogens-08-00181" ref-type="bibr">3</xref>], while in non-zoonotic livestock diseases production considerations dominate [<xref rid="B4-pathogens-08-00181" ref-type="bibr">4</xref>,<xref rid="B5-pathogens-08-00181" ref-type="bibr">5</xref>]. In contrast, social environments that promote collective action can encourage vaccination [<xref rid="B6-pathogens-08-00181" ref-type="bibr">6</xref>]. While the dissonance between public health objectives and individual actions is often attributed to these heterogenous individual factors, the disease characteristics, including the severity and timing of infection, likewise affect the decision by influencing the amount of uncertainty involved in the decision process. </p><p>Foot-and-mouth disease (FMD) presents a case whereby the decision to vaccinate involves more than individual deterministic preferences, as uncertainty of vaccine efficacy and vaccine matching also play important roles. FMD is a highly contagious, non-zoonotic viral disease that affects cloven-hoofed animals, including cattle, sheep, and goats [<xref rid="B7-pathogens-08-00181" ref-type="bibr">7</xref>]. In Africa, FMD-associated production losses amount to around US$2.3 billion annually [<xref rid="B8-pathogens-08-00181" ref-type="bibr">8</xref>] with the livestock-keeping households directly affected through reduced milk production, lost animal draught power, mortality of young stock, and lost market access [<xref rid="B7-pathogens-08-00181" ref-type="bibr">7</xref>]. Similar to vaccination for other endemic livestock diseases, vaccination for FMD may help reduce these impacts to improve household income, wealth, and food security [<xref rid="B7-pathogens-08-00181" ref-type="bibr">7</xref>,<xref rid="B9-pathogens-08-00181" ref-type="bibr">9</xref>]. This is particularly relevant given livestock keepers in sub-Saharan Africa are disproportionately characterized by extreme poverty [<xref rid="B10-pathogens-08-00181" ref-type="bibr">10</xref>]. Vaccination for foot-and-mouth disease, along with transnational coordination of policies, contribute to control in South America [<xref rid="B11-pathogens-08-00181" ref-type="bibr">11</xref>], but the complex spatial and temporal dynamics of multiple viral serotypes with evolving sub-types [<xref rid="B12-pathogens-08-00181" ref-type="bibr">12</xref>], along with limited infrastructural support to monitor and detect outbreaks within an extensive, pastoral and agro-pastoral system [<xref rid="B13-pathogens-08-00181" ref-type="bibr">13</xref>] complicates the provision of vaccines in East Africa. The presence of multiple FMD virus types requires either vaccines matched to the circulating virus or sufficiently high potency vaccines to prevent infection [<xref rid="B14-pathogens-08-00181" ref-type="bibr">14</xref>]. Besides monovalent vaccines, bivalent vaccines (SAT1 and SAT2) and trivalent vaccines (SATs, O, and A) are used in Africa [<xref rid="B14-pathogens-08-00181" ref-type="bibr">14</xref>]. However, unlike in South Africa, where vaccination accompanies movement restrictions at the wildlife-livestock interface where FMD has been shown to spread [<xref rid="B15-pathogens-08-00181" ref-type="bibr">15</xref>], in East Africa, inter-herd contacts primarily contribute to transmission [<xref rid="B12-pathogens-08-00181" ref-type="bibr">12</xref>]. From a household perspective, separating livestock to impose vaccination or other control measures, such as that used in southern Africa, unduly burdens the livelihoods of small-scale livestock owners who rely upon moving animals for market access and grazing [<xref rid="B16-pathogens-08-00181" ref-type="bibr">16</xref>].</p><p>Understanding how the characteristics of a disease and uncertainty of vaccine efficacy influence the individual&#x02019;s decision to employ disease control measures is important for devising effective control interventions. To this end, we evaluate the decision to vaccinate for FMD in the context of East Africa, where households face persistent disease threat but present with low-vaccination rates. We incorporate these conditions into a traditional vaccination game model by changing the payoff structure to reflect the FMD vaccination scenario. Our theoretical results substantiate empirical findings that attribute vaccination concerns to the quality of the vaccine [<xref rid="B17-pathogens-08-00181" ref-type="bibr">17</xref>] and extend these findings by showing that these perceptions align with expected behavior given the underlying disease characteristics in the context of East Africa. </p></sec><sec id="sec2-pathogens-08-00181"><title>2. Materials and Methods</title><sec><title>Vaccination Game Setting</title><p>We use game theory to depict the optimal decisions for vaccination strategies with contrasting assumptions about information pertaining to vaccine quality. Game theory has been applied to model various vaccination decisions for the advantage of demonstrating the complex social dynamics that influence vaccination in a theoretical framework [<xref rid="B18-pathogens-08-00181" ref-type="bibr">18</xref>]. For example, the incorporation of individual behaviors into epidemiological models using the strategic framework of game theory reveals that self-protective behavior influences disease spread in highly contagious epidemics [<xref rid="B19-pathogens-08-00181" ref-type="bibr">19</xref>]. Similarly, game theory has demonstrated how the pursuit of self-interest changes vaccination uptake overtime [<xref rid="B20-pathogens-08-00181" ref-type="bibr">20</xref>] and is likely determined by previous experience or exposure to the disease [<xref rid="B21-pathogens-08-00181" ref-type="bibr">21</xref>]. In contrast to these games that examine differential individual behavior with respect to the evolution of the disease over time, we use a one-shot game to emphasize the role vaccine efficacy and matching play in the decision process. This framework further describes how current circumstances of FMD in East Africa help explain existing findings of low-vaccine uptake [<xref rid="B12-pathogens-08-00181" ref-type="bibr">12</xref>,<xref rid="B17-pathogens-08-00181" ref-type="bibr">17</xref>].</p><p>Three stylized games outline separate landscapes for the vaccination decision-making process. The first game depicts decisions for an unspecified vaccine with a moderate protection efficacy and cost that closely resembles the vaccination game for seasonal influenza with self-interested individuals [<xref rid="B22-pathogens-08-00181" ref-type="bibr">22</xref>]. The second game adapts the first to apply to commercial livestock vaccination in a developed country context. The third game then depicts the theoretical decision for uptake of an FMD vaccine in East Africa. Minimal reductions in infection risk characterize the FMD vaccine. For each model we assume a simultaneous-move, one-shot game with homogenous information on the economic costs and losses of disease. The players consist of the individual and others in the community. Each player has two strategies, vaccinate or do not vaccinate, with the payoffs corresponding to the economic costs of each decision given the actions of the other player. While we focus on these three games, other games could be used to motivate the subsequent discussion.</p></sec></sec><sec sec-type="results" id="sec3-pathogens-08-00181"><title>3. Results</title><sec id="sec3dot1-pathogens-08-00181"><title>3.1. Strategies and Payoffs</title><p>In a traditional vaccination game, non-vaccination represents the Nash equilibrium (<xref rid="pathogens-08-00181-t001" ref-type="table">Table 1</xref>). To portray this decision in a simplified, one-shot game, we assume that &#x02018;free riders&#x02019; who do not vaccinate benefit from herd immunity. If the individual vaccinates, then the individual receives protection from the disease, but pays the cost of the vaccine while the community either chooses to also vaccinate (and thus sustain the same conditions) (&#x02212;3, &#x02212;3), or free ride on the protective immunity from the vaccinators (&#x02212;5, 0). The &#x02018;cooperators&#x02019; who vaccinate receive a lower payoff. If neither player vaccinates, then both face the risk of infection, but do not suffer the costs of vaccination (&#x02212;1, &#x02212;1). In this game, non-vaccination aligns with individual self-interested behavior, especially when adverse vaccine beliefs accompany the decision [<xref rid="B23-pathogens-08-00181" ref-type="bibr">23</xref>]. To motivate vaccination, either the cost of the vaccine must be sufficiently low or the perceived risk of infection (and consequences thereof) sufficiently high.</p><p>For infectious livestock diseases with significant individual costs in commercial agriculture, vaccination is often the dominant individual strategy (<xref rid="pathogens-08-00181-t002" ref-type="table">Table 2</xref>). We assume that a vaccine offers a known probability of protection and the cost of vaccination is less than the costs and losses from an infected herd. If an individual livestock-owning household does not vaccinate the herd, given the payoff structure in <xref rid="pathogens-08-00181-t002" ref-type="table">Table 2</xref> that corresponds to the incentive structure for vaccinating in commercial settings, the individual will not free ride on the immunity provided by others that vaccinate (&#x02212;10, &#x02212;5). If no one vaccinates, the increased likelihood of infection offers the worst payoff for both players (&#x02212;10, &#x02212;10). Vaccinating with effective livestock vaccines at market price represents the secure strategy (&#x02212;5, &#x02212;5). Regardless of others, vaccinating households incur a small vaccination cost but forego the immediate production losses and longer-term disease implications, including mortality and morbidity risks. Here we have assumed no free riding, for comparison purposes, which could be incorporated, but would not necessarily alter the main points of this paper.</p><p>In <xref rid="pathogens-08-00181-t003" ref-type="table">Table 3</xref>, uncertain vaccine efficacy and potency coupled with high infection risk defines the FMD game in an endemic East African setting [<xref rid="B12-pathogens-08-00181" ref-type="bibr">12</xref>]. Individuals pay for a vaccine with no assurance of the vaccine&#x02019;s ability to prevent infection. In reality, the individuals have information on the efficacy of past FMD vaccines and control policies, which resulted in limited to no protection against clinical symptoms. If an individual livestock-owning household decides to vaccinate, the individual incurs the cost of the vaccine, the related costs from treating an infected animal, and suffers animal productivity losses, regardless of others&#x02019; decisions (&#x02212;15). If an individual does not vaccinate, then the individual only sustains the costs and losses from the infection (&#x02212;5). There is no gain to free riding on the vaccination of others. Without the assurance that the vaccine offers a sufficient likelihood of disease protection, the dominate strategy for both players is to not vaccinate (&#x02212;5, &#x02212;5). </p></sec><sec id="sec3dot2-pathogens-08-00181"><title>3.2. Decision Analysis</title><p>The high likelihood of infection coupled with the potential production losses attributed to FMD suggest vaccination would address public health concerns. The rapid spread of FMD within dense populations that graze on communal lands makes infection inevitable amongst non-vaccinated animals. Yet, using a vaccine of insufficient potency to prevent or stop the circulating FMD type incurs the additional vaccination cost on top of the lost animal productivity from infection with little to no benefits. Unlike in traditional vaccination games whereby free riding obfuscates vaccination uptake rates, uncertainty towards the protective efficacy of the FMD vaccine reduces incentive to vaccinate in endemic parts of East Africa.</p><p>Practically, FMD vaccines need to prevent FMD with a sufficiently high probability. Altering this property then allows the FMD game to resemble that of <xref rid="pathogens-08-00181-t002" ref-type="table">Table 2</xref>. This requires enhancing the payoff of vaccinating by improving vaccine efficacy or reducing infection risk. Subsidizing vaccines to address price constraints may increase uptake, but for FMD, this does not necessarily prevent or stop disease spread. Instead, the assumption of vaccine efficacy may increase vaccination costs if significant barriers to improving vaccine quality exist. Reducing inter-herd contact through restricted animal movements addresses infection risk but the lack of access to markets and constraints on traditional open grazing practices limits implementation in East Africa [<xref rid="B24-pathogens-08-00181" ref-type="bibr">24</xref>].</p></sec></sec><sec sec-type="discussion" id="sec4-pathogens-08-00181"><title>4. Discussion</title><p>A simple game theory model demonstrates how the presence of multiple FMD serotypes and sub-types coupled with the absence of a potent vaccine can make vaccination the least appealing disease control option. This is in contrast to other livestock vaccination programs with one vaccine or even vaccination for seasonal influenza where the vaccine may offer some protection [<xref rid="B25-pathogens-08-00181" ref-type="bibr">25</xref>]. In East Africa, without the assurance of a certain level of protective efficacy from vaccinating for FMD, vaccination presents an added lost cost on top of the inevitable costs of therapeutic, post-exposure treatments and the associated loss in animal productivity from infection. In effect, without a vaccine matched to the circulating serotype, vaccination is an extraneous expense without any assured benefits. Households in East Africa then reflect rational decision-making when choosing not to vaccinate whereby empirical evidence collected in 2016 and from 2012&#x02013;2015 found less than five percent of households vaccinated for FMD [<xref rid="B12-pathogens-08-00181" ref-type="bibr">12</xref>,<xref rid="B17-pathogens-08-00181" ref-type="bibr">17</xref>].</p><p>Improved information about the disease offers an opportunity to reduce the barriers to vaccination. Often, when low vaccination uptake is believed to occur from lack of understanding on the benefits of vaccination, educating local populations on vaccine technology and information campaigns to promote disease control are the preferred interventions [<xref rid="B26-pathogens-08-00181" ref-type="bibr">26</xref>]. From a theoretical perspective, if low uptake reflects self-interested motives and free riding tendencies, then combating these coordination failures through financial incentives may reduce asymmetries that deter public health objectives for elimination [<xref rid="B27-pathogens-08-00181" ref-type="bibr">27</xref>]. However, since households currently demonstrate rational behavior by not vaccinating, the challenge to FMD vaccination rests in increasing the likelihood of the vaccine preventing or stopping infection. Similar to influenza vaccination efforts that compile information early to predict the upcoming season&#x02019;s vaccination needs [<xref rid="B28-pathogens-08-00181" ref-type="bibr">28</xref>], the diversity of FMD serotypes and sub-types along with the limited use of polyvalent vaccines in East Africa requires sufficient warning to vaccinate. Unlike other approaches to vaccination uptake, encouraging the use of early detection through diagnostic testing or other surveillance measures provides timely information to reduce uncertainty surrounding disease status and potential control options [<xref rid="B29-pathogens-08-00181" ref-type="bibr">29</xref>] while improved information on disease patterns reduces infection uncertainty.</p><p>For vaccination, assessing the disease in context is the first step in deciding whether vaccination is necessary. In some instances, vaccination may not improve individual health outcomes. Addressing individual preferences and adversities towards vaccines incorrectly targets the source of low uptake. Livestock-dependent populations in East Africa already vaccinate for the cattle diseases East Coast Fever and contagious bovine pleuropneumonia when vaccines become available [<xref rid="B30-pathogens-08-00181" ref-type="bibr">30</xref>,<xref rid="B31-pathogens-08-00181" ref-type="bibr">31</xref>]. The global eradication of the rinderpest with vaccination further emphasizes the potential for vaccines designed with local communities in mind to address the livestock disease burden [<xref rid="B32-pathogens-08-00181" ref-type="bibr">32</xref>]. Once FMD vaccines demonstrate improved protection, targeting of susceptible populations to enhance vaccine efficacy [<xref rid="B33-pathogens-08-00181" ref-type="bibr">33</xref>] and acknowledging the individual dynamic factors that may deter population level elimination [<xref rid="B34-pathogens-08-00181" ref-type="bibr">34</xref>] come next. Vaccination is not the only disease control measure. For regions with multiple FMD types circulating, identifying patterns in FMD spread posits an additional approach to reducing the challenge of enhancing FMD vaccine efficacy, primarily by predicting vaccine demand instead of necessitating a polyvalent vaccine to address all serotypes [<xref rid="B12-pathogens-08-00181" ref-type="bibr">12</xref>]. The improved vaccine matching that can occur by understanding the disease spread may then provide spillover benefits, including impacting antibiotic usage and enhancing household expenditures on human health, education, and food [<xref rid="B9-pathogens-08-00181" ref-type="bibr">9</xref>].</p><p>The strategies presented here represent a simplified version of the vaccination game for complex diseases with ineffective or non-existent vaccines. The information is particularly relevant given current global challenges to create FMD vaccines specific to East Africa [<xref rid="B35-pathogens-08-00181" ref-type="bibr">35</xref>]. The framework developed through the game theoretical model encourages those individuals seeking to define the demand for FMD vaccines to consider the costs of a low-quality vaccine and lack of quality assurance. Extending our theoretical analysis to a dynamic setting with repeated interactions and improved vaccine quality would provide an initial understanding on the stability of vaccination uptake if vaccination rates increased [<xref rid="B20-pathogens-08-00181" ref-type="bibr">20</xref>]. However, first understanding how to improve the efficacy of livestock vaccines in the field and identifying additional critical decision points to ensuring the optimal provision of health technologies will help increase the effectiveness of livestock inputs while enhancing returns to household wellbeing. Once FMD vaccines for East Africa ensure households may receive some protection from FMD, we can then perform cost-effectiveness analyses to evaluate the impact across the diverse livestock systems, similar to studies evaluating current FMD vaccination practices elsewhere [<xref rid="B24-pathogens-08-00181" ref-type="bibr">24</xref>].</p></sec></body><back><notes><title>Author Contributions</title><p>Conceptualization, A.F.R. and T.L.M.; Formal analysis, A.F.R. and T.L.M.; Writing&#x02014;original draft preparation, A.F.R.; Writing&#x02014;reviewing and editing, A.F.R. and T.L.M.; Supervision, T.L.M.</p></notes><notes><title>Funding</title><p>This research was funded by the Bill &#x00026; Melinda Gates Foundation and the Paul G. Allen School for Global Animal Health, grant number OPP1083453. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pathogens-08-00181"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>N.T.</given-names></name><name><surname>Chapman</surname><given-names>G.B.</given-names></name><name><surname>Gibbons</surname><given-names>F.X.</given-names></name><name><surname>Gerrard</surname><given-names>M.</given-names></name><name><surname>McCaul</surname><given-names>K.D.</given-names></name><name><surname>Weinstein</surname><given-names>N.D.</given-names></name></person-group><article-title>Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination</article-title><source>Health Psychol.</source><year>2007</year><volume>26</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.1037/0278-6133.26.2.136</pub-id><?supplied-pmid 17385964?><pub-id pub-id-type="pmid">17385964</pub-id></element-citation></ref><ref id="B2-pathogens-08-00181"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>V.C.</given-names></name><name><surname>Smieszek</surname><given-names>T.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Rainey</surname><given-names>J.J.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Uzicanin</surname><given-names>A.</given-names></name><name><surname>Salathe</surname><given-names>M.</given-names></name></person-group><article-title>Positive Network Assortativity of Influenza Vaccination at a High School: Implications for Outbreak Risk and Herd Immunity</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e87042</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0087042</pub-id><?supplied-pmid 24505274?><pub-id pub-id-type="pmid">24505274</pub-id></element-citation></ref><ref id="B3-pathogens-08-00181"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>P.</given-names></name><name><surname>Rauber</surname><given-names>D.</given-names></name><name><surname>Betsch</surname><given-names>C.</given-names></name><name><surname>Lidolt</surname><given-names>G.</given-names></name><name><surname>Denker</surname><given-names>M.L.</given-names></name></person-group><article-title>Barriers of influenza vaccination intention and behavior&#x02014;A systematic review of influenza vaccine hesitancy, 2005&#x02013;2016</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><fpage>2005</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0170550</pub-id><?supplied-pmid 28125629?><pub-id pub-id-type="pmid">28125629</pub-id></element-citation></ref><ref id="B4-pathogens-08-00181"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutua</surname><given-names>E.</given-names></name><name><surname>De Haan</surname><given-names>N.</given-names></name><name><surname>Tumusiime</surname><given-names>D.</given-names></name><name><surname>Jost</surname><given-names>C.</given-names></name><name><surname>Bett</surname><given-names>B.</given-names></name></person-group><article-title>A Qualitative Study on Gendered Barriers to Livestock Vaccine Uptake in Kenya and Uganda and Their Implications on Rift Valley Fever Control</article-title><source>Vaccines</source><year>2019</year><volume>7</volume><elocation-id>86</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines7030086</pub-id></element-citation></ref><ref id="B5-pathogens-08-00181"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barasa</surname><given-names>M.</given-names></name><name><surname>Catley</surname><given-names>A.</given-names></name><name><surname>Machuchu</surname><given-names>D.</given-names></name><name><surname>Laqua</surname><given-names>H.</given-names></name><name><surname>Puot</surname><given-names>E.</given-names></name><name><surname>Kot</surname><given-names>D.T.</given-names></name><name><surname>Ikiror</surname><given-names>D.</given-names></name></person-group><article-title>Foot-and-Mouth Disease Vaccination in South Sudan: Benefit-Cost Analysis and Livelihoods Impact</article-title><source>Transbound. Emerg. Dis.</source><year>2008</year><volume>55</volume><fpage>339</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1111/j.1865-1682.2008.01042.x</pub-id><pub-id pub-id-type="pmid">18786073</pub-id></element-citation></ref><ref id="B6-pathogens-08-00181"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hm</surname><given-names>R.</given-names></name><name><surname>Betsch</surname><given-names>C.</given-names></name><name><surname>Korn</surname><given-names>L.</given-names></name></person-group><article-title>Selfish-rational non-vaccination: Experimental evidence from an interactive vaccination game</article-title><source>J. Econ. Behav. Organ.</source><year>2016</year><volume>131</volume><fpage>183</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.jebo.2015.11.008</pub-id></element-citation></ref><ref id="B7-pathogens-08-00181"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight-Jones</surname><given-names>T.J.D.</given-names></name><name><surname>Rushton</surname><given-names>J.</given-names></name></person-group><article-title>The economic impacts of foot and mouth disease&#x02014;What are they, how big are they and where do they occur?</article-title><source>Prev. Vet. Med.</source><year>2013</year><volume>112</volume><fpage>162</fpage><lpage>173</lpage></element-citation></ref><ref id="B8-pathogens-08-00181"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight-Jones</surname><given-names>T.J.D.</given-names></name><name><surname>McLaws</surname><given-names>M.</given-names></name><name><surname>Rushton</surname><given-names>J.</given-names></name></person-group><article-title>Foot-and-mouth disease impact on smallholders&#x02014;What do we know, what don&#x02019;t we know and how can we find out more?</article-title><source>Transbound. Emerg. Dis.</source><year>2016</year><volume>64</volume><fpage>1079</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1111/tbed.12507</pub-id><pub-id pub-id-type="pmid">27167976</pub-id></element-citation></ref><ref id="B9-pathogens-08-00181"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>T.L.</given-names></name><name><surname>Yoder</surname><given-names>J.</given-names></name><name><surname>Deboch</surname><given-names>T.</given-names></name><name><surname>McElwain</surname><given-names>T.F.</given-names></name><name><surname>Palmer</surname><given-names>G.H.</given-names></name></person-group><article-title>Livestock vaccinations translate into increased human capital and school attendance by girls</article-title><source>Sci. Adv.</source><year>2016</year><volume>2</volume><fpage>e1601410</fpage><pub-id pub-id-type="doi">10.1126/sciadv.1601410</pub-id><pub-id pub-id-type="pmid">27990491</pub-id></element-citation></ref><ref id="B10-pathogens-08-00181"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Otte</surname><given-names>J.</given-names></name><name><surname>Costales</surname><given-names>A.</given-names></name><name><surname>Dijkman</surname><given-names>J.</given-names></name><name><surname>Pica-Ciamarra</surname><given-names>U.</given-names></name><name><surname>Robinson</surname><given-names>T.</given-names></name><name><surname>Ahuja</surname><given-names>V.</given-names></name><name><surname>Ly</surname><given-names>C.</given-names></name><name><surname>Roland-Holst</surname><given-names>D.</given-names></name></person-group><source>Livestock sector for poverty Reduction: An Economic and Policy Perspective&#x02014;Livestock&#x02019;s Many Virtues</source><publisher-name>Food and Agriculture Organization of the United Nations</publisher-name><publisher-loc>Rome, Italy</publisher-loc><year>2012</year><size units="pages">161p</size></element-citation></ref><ref id="B11-pathogens-08-00181"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naranjo</surname><given-names>J.</given-names></name><name><surname>Cosivi</surname><given-names>O.</given-names></name></person-group><article-title>Elimination of foot-and-mouth disease in South America: Lessons and challenges</article-title><source>Philos. Trans. R. Soc. B Biol. Sci.</source><year>2013</year><volume>368</volume><fpage>20120381</fpage><pub-id pub-id-type="doi">10.1098/rstb.2012.0381</pub-id></element-citation></ref><ref id="B12-pathogens-08-00181"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey-Bryars</surname><given-names>M.</given-names></name><name><surname>Reeve</surname><given-names>R.</given-names></name><name><surname>Bastola</surname><given-names>U.</given-names></name><name><surname>Knowles</surname><given-names>N.J.</given-names></name><name><surname>Auty</surname><given-names>H.</given-names></name><name><surname>Bachanek-Bankowska</surname><given-names>K.</given-names></name><name><surname>Fowler</surname><given-names>V.L.</given-names></name><name><surname>Fyumagwa</surname><given-names>R.</given-names></name><name><surname>Kazwala</surname><given-names>R.</given-names></name><name><surname>Kibona</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches</article-title><source>Nat. Ecol. Evol.</source><year>2018</year><volume>2</volume><fpage>1449</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1038/s41559-018-0636-x</pub-id><pub-id pub-id-type="pmid">30082738</pub-id></element-citation></ref><ref id="B13-pathogens-08-00181"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliday</surname><given-names>J.E.</given-names></name><name><surname>Hampson</surname><given-names>K.</given-names></name><name><surname>Hanley</surname><given-names>N.</given-names></name><name><surname>Lembo</surname><given-names>T.</given-names></name><name><surname>Sharp</surname><given-names>J.P.</given-names></name><name><surname>Haydon</surname><given-names>D.T.</given-names></name><name><surname>Cleaveland</surname><given-names>S.</given-names></name></person-group><article-title>Driving improvements in emerging disease surveillance through locally relevant capacity strengthening</article-title><source>Science</source><year>2017</year><volume>357</volume><fpage>146</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1126/science.aam8332</pub-id><pub-id pub-id-type="pmid">28706036</pub-id></element-citation></ref><ref id="B14-pathogens-08-00181"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parida</surname><given-names>S.</given-names></name></person-group><article-title>Vaccination against foot-and-mouth disease virus: Strategies and effectiveness</article-title><source>Expert Rev. Vaccines</source><year>2009</year><volume>8</volume><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1586/14760584.8.3.347</pub-id><?supplied-pmid 19249976?><pub-id pub-id-type="pmid">19249976</pub-id></element-citation></ref><ref id="B15-pathogens-08-00181"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruckner</surname><given-names>G.</given-names></name><name><surname>Vosloo</surname><given-names>W.</given-names></name><name><surname>Du Plessis</surname><given-names>B.</given-names></name><name><surname>Kloeck</surname><given-names>P.</given-names></name><name><surname>Connoway</surname><given-names>F.</given-names></name><name><surname>Ekron</surname><given-names>M.</given-names></name><name><surname>Weaver</surname><given-names>D.</given-names></name><name><surname>Dickason</surname><given-names>C.</given-names></name><name><surname>Schreuder</surname><given-names>F.</given-names></name><name><surname>Marais</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Foot and mouth disease: The experience of South Africa</article-title><source>Rev. Sci. Tech. l&#x02019;OIE</source><year>2002</year><volume>21</volume><fpage>751</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.20506/rst.21.3.1368</pub-id><?supplied-pmid 12523712?><pub-id pub-id-type="pmid">12523712</pub-id></element-citation></ref><ref id="B16-pathogens-08-00181"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemberu</surname><given-names>W.T.</given-names></name><name><surname>Mourits</surname><given-names>M.C.M.</given-names></name><name><surname>Hogeveen</surname><given-names>H.</given-names></name></person-group><article-title>Farmers&#x02019; Intentions to Implement Foot and Mouth Disease Control Measures in Ethiopia</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0138363</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0138363</pub-id><?supplied-pmid 26375391?><pub-id pub-id-type="pmid">26375391</pub-id></element-citation></ref><ref id="B17-pathogens-08-00181"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Railey</surname><given-names>A.F.</given-names></name><name><surname>Lembo</surname><given-names>T.</given-names></name><name><surname>Palmer</surname><given-names>G.H.</given-names></name><name><surname>Shirima</surname><given-names>G.M.</given-names></name><name><surname>Marsh</surname><given-names>T.L.</given-names></name></person-group><article-title>Spatial and temporal risk as drivers for adoption of foot and mouth disease vaccination</article-title><source>Vaccine</source><year>2018</year><volume>36</volume><fpage>5077</fpage><lpage>5083</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2018.06.069</pub-id><pub-id pub-id-type="pmid">29997035</pub-id></element-citation></ref><ref id="B18-pathogens-08-00181"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>G.B.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Vietri</surname><given-names>J.</given-names></name><name><surname>Ibuka</surname><given-names>Y.</given-names></name><name><surname>Thomas</surname><given-names>D.</given-names></name><name><surname>Yoon</surname><given-names>H.</given-names></name><name><surname>Galvani</surname><given-names>A.P.</given-names></name></person-group><article-title>Using Game Theory to Examine Incentives in Influenza Vaccination Behavior</article-title><source>Psychol. Sci.</source><year>2012</year><volume>23</volume><fpage>1008</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1177/0956797612437606</pub-id><pub-id pub-id-type="pmid">22810166</pub-id></element-citation></ref><ref id="B19-pathogens-08-00181"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reluga</surname><given-names>T.C.</given-names></name></person-group><article-title>Game Theory of Social Distancing in Response to an Epidemic</article-title><source>PLoS Comput. Biol.</source><year>2010</year><volume>6</volume><elocation-id>e1000793</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000793</pub-id><?supplied-pmid 20523740?><pub-id pub-id-type="pmid">20523740</pub-id></element-citation></ref><ref id="B20-pathogens-08-00181"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reluga</surname><given-names>T.C.</given-names></name><name><surname>Bauch</surname><given-names>C.T.</given-names></name><name><surname>Galvani</surname><given-names>A.P.</given-names></name></person-group><article-title>Evolving public perceptions and stability in vaccine uptake</article-title><source>Math. Biosci.</source><year>2006</year><volume>204</volume><fpage>185</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.mbs.2006.08.015</pub-id><pub-id pub-id-type="pmid">17056073</pub-id></element-citation></ref><ref id="B21-pathogens-08-00181"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibuka</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Vietri</surname><given-names>J.</given-names></name><name><surname>Chapman</surname><given-names>G.B.</given-names></name><name><surname>Galvani</surname><given-names>A.P.</given-names></name></person-group><article-title>Free-Riding Behavior in Vaccination Decisions: An Experimental Study</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e87164</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0087164</pub-id><pub-id pub-id-type="pmid">24475246</pub-id></element-citation></ref><ref id="B22-pathogens-08-00181"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvani</surname><given-names>A.P.</given-names></name><name><surname>Reluga</surname><given-names>T.C.</given-names></name><name><surname>Chapman</surname><given-names>G.B.</given-names></name></person-group><article-title>Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>5692</fpage><lpage>5697</lpage><pub-id pub-id-type="doi">10.1073/pnas.0606774104</pub-id><?supplied-pmid 17369367?><pub-id pub-id-type="pmid">17369367</pub-id></element-citation></ref><ref id="B23-pathogens-08-00181"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauch</surname><given-names>C.T.</given-names></name><name><surname>Earn</surname><given-names>D.J.D.</given-names></name></person-group><article-title>Vaccination and the theory of games</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>13391</fpage><lpage>13394</lpage><pub-id pub-id-type="doi">10.1073/pnas.0403823101</pub-id><?supplied-pmid 15329411?><pub-id pub-id-type="pmid">15329411</pub-id></element-citation></ref><ref id="B24-pathogens-08-00181"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemberu</surname><given-names>W.T.</given-names></name><name><surname>Mourits</surname><given-names>M.</given-names></name><name><surname>Rushton</surname><given-names>J.</given-names></name><name><surname>Hogeveen</surname><given-names>H.</given-names></name></person-group><article-title>Cost-benefit analysis of foot and mouth disease control in Ethiopia</article-title><source>Prev. Vet. Med.</source><year>2016</year><volume>132</volume><fpage>67</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2016.08.008</pub-id><?supplied-pmid 27664449?><pub-id pub-id-type="pmid">27664449</pub-id></element-citation></ref><ref id="B25-pathogens-08-00181"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterholm</surname><given-names>M.T.</given-names></name><name><surname>Kelley</surname><given-names>N.S.</given-names></name><name><surname>Sommer</surname><given-names>A.</given-names></name><name><surname>A Belongia</surname><given-names>E.</given-names></name></person-group><article-title>Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis</article-title><source>Lancet Infect. Dis.</source><year>2012</year><volume>12</volume><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(11)70295-X</pub-id><pub-id pub-id-type="pmid">22032844</pub-id></element-citation></ref><ref id="B26-pathogens-08-00181"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>G.J.</given-names></name><name><surname>Shen</surname><given-names>A.K.</given-names></name><name><surname>Schwartz</surname><given-names>J.L.</given-names></name></person-group><article-title>Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights</article-title><source>Vaccine</source><year>2017</year><volume>35</volume><fpage>5543</fpage><lpage>5550</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2017.08.064</pub-id><?supplied-pmid 28886947?><pub-id pub-id-type="pmid">28886947</pub-id></element-citation></ref><ref id="B27-pathogens-08-00181"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennessy</surname><given-names>D.A.</given-names></name><name><surname>Wolf</surname><given-names>C.A.</given-names></name></person-group><article-title>Asymmetric Information, Externalities and Incentives in Animal Disease Prevention and Control</article-title><source>J. Agric. Econ.</source><year>2015</year><volume>69</volume><fpage>226</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1111/1477-9552.12113</pub-id></element-citation></ref><ref id="B28-pathogens-08-00181"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paules</surname><given-names>C.I.</given-names></name><name><surname>Sullivan</surname><given-names>S.G.</given-names></name><name><surname>Subbarao</surname><given-names>K.</given-names></name><name><surname>Fauci</surname><given-names>A.S.</given-names></name></person-group><article-title>Chasing Seasonal Influenza&#x02014;The Need for a Universal Influenza Vaccine</article-title><source>N. Engl. J. Med.</source><year>2018</year><volume>378</volume><fpage>7</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJMp1714916</pub-id><?supplied-pmid 29185857?><pub-id pub-id-type="pmid">29185857</pub-id></element-citation></ref><ref id="B29-pathogens-08-00181"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nouvellet</surname><given-names>P.</given-names></name><name><surname>Garske</surname><given-names>T.</given-names></name><name><surname>Mills</surname><given-names>H.L.</given-names></name><name><surname>Nedjati-Gilani</surname><given-names>G.</given-names></name><name><surname>Hinsley</surname><given-names>W.</given-names></name><name><surname>Blake</surname><given-names>I.M.</given-names></name><name><surname>Van Kerkhove</surname><given-names>M.D.</given-names></name><name><surname>Cori</surname><given-names>A.</given-names></name><name><surname>Dorigatti</surname><given-names>I.</given-names></name><name><surname>Jombart</surname><given-names>T.</given-names></name><etal/></person-group><article-title>The role of rapid diagnostics in managing Ebola epidemics</article-title><source>Nature</source><year>2015</year><volume>528</volume><fpage>S109</fpage><lpage>S116</lpage><pub-id pub-id-type="doi">10.1038/nature16041</pub-id><pub-id pub-id-type="pmid">26633764</pub-id></element-citation></ref><ref id="B30-pathogens-08-00181"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>B.D.</given-names></name></person-group><article-title>The control of East Coast fever of cattle by live parasite vaccination: A science-to-impact narrative</article-title><source>One Health</source><year>2016</year><volume>2</volume><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.onehlt.2016.07.002</pub-id><pub-id pub-id-type="pmid">28616483</pub-id></element-citation></ref><ref id="B31-pathogens-08-00181"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kairu-Wanyoike</surname><given-names>S.W.</given-names></name><name><surname>Kaitibie</surname><given-names>S.</given-names></name><name><surname>Heffernan</surname><given-names>C.</given-names></name><name><surname>Taylor</surname><given-names>N.M.</given-names></name><name><surname>Gitau</surname><given-names>G.K.</given-names></name><name><surname>Kiara</surname><given-names>H.</given-names></name><name><surname>McKeever</surname><given-names>D.</given-names></name></person-group><article-title>Willingness to pay for contagious bovine pleuropneumonia vaccination in Narok South District of Kenya</article-title><source>Prev. Veter Med.</source><year>2014</year><volume>115</volume><fpage>130</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2014.03.028</pub-id></element-citation></ref><ref id="B32-pathogens-08-00181"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariner</surname><given-names>J.C.</given-names></name><name><surname>House</surname><given-names>J.A.</given-names></name><name><surname>Mebus</surname><given-names>C.A.</given-names></name><name><surname>Sollod</surname><given-names>A.E.</given-names></name><name><surname>Chibeu</surname><given-names>D.</given-names></name><name><surname>Jones</surname><given-names>B.A.</given-names></name><name><surname>Roeder</surname><given-names>P.L.</given-names></name><name><surname>Admassu</surname><given-names>B.</given-names></name><name><surname>van&#x02019;t Klooster</surname><given-names>G.G.</given-names></name></person-group><article-title>Rinderpest eradication: Appropriate technology and social Innovations</article-title><source>Science</source><year>2012</year><volume>337</volume><fpage>1309</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1126/science.1223805</pub-id><?supplied-pmid 22984063?><pub-id pub-id-type="pmid">22984063</pub-id></element-citation></ref><ref id="B33-pathogens-08-00181"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon</surname><given-names>P.</given-names></name><name><surname>Wieland</surname><given-names>B.</given-names></name><name><surname>Mateus</surname><given-names>A.L.</given-names></name><name><surname>Dewberry</surname><given-names>C.</given-names></name></person-group><article-title>Pig farmers&#x02019; perceptions, attitudes, influences and management of information in the decision-making process for disease control</article-title><source>Prev. Veter Med.</source><year>2014</year><volume>116</volume><fpage>223</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2013.08.004</pub-id><?supplied-pmid 24016600?><pub-id pub-id-type="pmid">24016600</pub-id></element-citation></ref><ref id="B34-pathogens-08-00181"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>H.J.</given-names></name></person-group><article-title>Politics and public trust shape vaccine risk perceptions</article-title><source>Nat. Hum. Behav.</source><year>2018</year><volume>2</volume><fpage>316</fpage><pub-id pub-id-type="doi">10.1038/s41562-018-0331-6</pub-id><?supplied-pmid 30962595?><pub-id pub-id-type="pmid">30962595</pub-id></element-citation></ref><ref id="B35-pathogens-08-00181"><label>35.</label><element-citation publication-type="web"><article-title>GALVmed to Manage Multimillion-Dollar AgResults Foot and Mouth Disease (FMD) Challenge Project&#x02014;GALVmed</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.galvmed.org/news/galvmed-to-manage-multimillion-dollar-agresults-foot-and-mouth-disease-fmd-challenge-project/">https://www.galvmed.org/news/galvmed-to-manage-multimillion-dollar-agresults-foot-and-mouth-disease-fmd-challenge-project/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-09-05">(accessed on 5 September 2019)</date-in-citation></element-citation></ref></ref-list></back><floats-group><table-wrap id="pathogens-08-00181-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-08-00181-t001_Table 1</object-id><label>Table 1</label><caption><p>Vaccine is effective.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Individual/Others</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccinate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Do not Vaccinate</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vaccinate</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;3, &#x02212;3)</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;5, 0)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Do not vaccinate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(0, &#x02212;5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;1, &#x02212;1)</td></tr></tbody></table></table-wrap><table-wrap id="pathogens-08-00181-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-08-00181-t002_Table 2</object-id><label>Table 2</label><caption><p>Vaccine is effective, long-term disease complications.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Individual/Others</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccinate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Do not Vaccinate</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vaccinate</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;5, &#x02212;5)</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;5, &#x02212;10)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Do not vaccinate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;10, &#x02212;5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;10, &#x02212;10)</td></tr></tbody></table></table-wrap><table-wrap id="pathogens-08-00181-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-08-00181-t003_Table 3</object-id><label>Table 3</label><caption><p>Vaccine is not effective.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Individual/Others</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccinate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Do not Vaccinate</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vaccinate</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;15, &#x02212;15)</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;15, &#x02212;5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Do not vaccinate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;5, &#x02212;15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;5, &#x02212;5)</td></tr></tbody></table></table-wrap></floats-group></article>